Cross License Agreement Sample Contracts

Zymeworks Inc. – Collaboration and Cross License Agreement (April 3rd, 2017)

THIS COLLABORATION AND CROSS LICENSE AGREEMENT (the Agreement), effective as of , 2016 (the Effective Date), by and between DAIICHI SANKYO CO., LTD., a corporation organized and existing under the laws of Japan, with its principal business office located at 3-5-1, Nihonbashi honcho, Chuo-ku, Tokyo, 103-8426, Japan (DS) and ZYMEWORKS INC., a corporation organized and existing under the laws of Canada, and extra provincially in British Columbia, having an address at 540-1385 West 8th Avenue, Vancouver, BC, Canada V6H 3V9 (Zymeworks). Zymeworks and DS are each referred to individually as a Party and together as the Parties.

Zymeworks Inc. – CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. [ *** ] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF a CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION. COLLABORATION AND CROSS LICENSE AGREEMENT Between ZYMEWORKS INC. And DAIICHI SANKYO CO., LTD. Confidential (March 20th, 2017)
Anthem Inc. – Blue Cross License Agreement (February 22nd, 2017)

WHEREAS, the Plan and/or its predecessor(s) in interest (collectively the "Plan") had the right to use the BLUE CROSS and BLUE CROSS Design service marks (collectively the "Licensed Marks") for health care plans in its service area, which was essentially local in nature;

Western Digital Corporation Renews Patent Cross-License Agreement With Samsung (December 6th, 2016)

IRVINE, Calif. Dec. 6, 2016 - Western Digital Corporation (NASDAQ: WDC), a world leader in storage technologies and solutions, today announced that it has signed a definitive royalty-bearing agreement with Samsung Electronics Co., Ltd. to renew the cross-license of the two companies semiconductor patent portfolios. The terms of the renewed agreement are retroactive to the end date of the prior agreement, which expired on August 14, 2016. The renewed agreement will run through December 31, 2024.

Versum Materials, LLC – Intellectual Property Cross-License Agreement (October 4th, 2016)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of September 29, 2016 (the Effective Date), is entered into by and between Air Products and Chemicals, Inc. (Air Products), a Delaware corporation with an address at 7201 Hamilton Boulevard, Allentown, Pennsylvania 18195, U.S.A., and Versum Materials U.S., LLC (Versum), a limited liability company organized under the laws of the State of Delaware with an address at 7201 Hamilton Boulevard, Allentown, Pennsylvania 18195, U.S.A. (both Air Products and Versum, a Party and collectively, the Parties).

Versum Materials, LLC – FORM OF INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT by and Between AIR PRODUCTS AND CHEMICALS, INC. And VERSUM MATERIALS U.S., LLC Dated as Of (September 7th, 2016)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of (the Effective Date), is entered into by and between Air Products and Chemicals, Inc. (Air Products), a Delaware corporation with an address at 7201 Hamilton Boulevard, Allentown, Pennsylvania, 18195, U.S.A., and Versum Materials U.S., LLC (Versum), a limited liability company organized under the laws of the State of Delaware with an address at , U.S.A. (both Air Products and Versum, a Party and collectively, the Parties).

Versum Materials, LLC – FORM OF INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT by and Between AIR PRODUCTS AND CHEMICALS, INC. And VERSUM MATERIALS, INC. Dated as Of (August 26th, 2016)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of (the Effective Date), is entered into by and between Air Products and Chemicals, Inc. (Air Products), a Delaware corporation with an address at 7201 Hamilton Boulevard, Allentown, Pennsylvania, 18195, U.S.A., and Versum Materials, Inc. (Versum), a corporation with an address at , U.S.A. (both Air Products and Versum, a Party and collectively, the Parties).

Versum Materials, LLC – INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT by and Between AIR PRODUCTS AND CHEMICALS, INC. And VERSUM MATERIALS, INC. Dated as Of (July 22nd, 2016)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of (the Effective Date), is entered into by and between Air Products and Chemicals, Inc. (Air Products), a Delaware corporation with an address at 7201 Hamilton Boulevard, Allentown, Pennsylvania, 18195, U.S.A., and Versum Materials, Inc. (Versum), a corporation with an address at , U.S.A. (both Air Products and Versum, a Party and collectively, the Parties).

Vertiv Co. – Form of Intellectual Property Cross License Agreement (June 17th, 2016)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of , 2016, is made and entered into by and between Emerson Electric Co., a Missouri corporation (Emerson), Vertiv Co., a Delaware corporation (NewCo) and [ ], a [ ] corporation (NewCo Sub) (each a Party and collectively, the Parties).

Selecta Biosciences Inc – Patent Cross-License Agreement (May 24th, 2016)

THIS PATENT CROSS-LICENSE AGREEMENT (Agreement) is entered into as of this 18th day of December, 2008 (the Effective Date) by and between BIND Biosciences Inc., a Delaware corporation, with a principal place of business at 101 Binney Street, Cambridge, Massachusetts 02142 (BIND) and Selecta Biosciences, Inc., a Delaware corporation, with a principal place of business at 480 Arsenal Street, Building One, Watertown, Massachusetts 02472 (Selecta), each of BIND and Selecta being a Party and collectively being the Parties.

Selecta Biosciences Inc – Patent Cross-License Agreement (March 18th, 2016)

THIS PATENT CROSS-LICENSE AGREEMENT (Agreement) is entered into as of this 18th day of December, 2008 (the Effective Date) by and between BIND Biosciences Inc., a Delaware corporation, with a principal place of business at 101 Binney Street, Cambridge, Massachusetts 02142 (BIND) and Selecta Biosciences, Inc., a Delaware corporation, with a principal place of business at 480 Arsenal Street, Building One, Watertown, Massachusetts 02472 (Selecta), each of BIND and Selecta being a Party and collectively being the Parties.

CROSS LICENSE AGREEMENT Between ASTERIAS and BIOTIME and ESI (February 22nd, 2016)

This CROSS-LICENSE AGREEMENT (the "Agreement") is entered into on February 16, 2016 (the "Effective Date") by and between Asterias Biotherapeutics, Inc., a Delaware corporation, having a place of business at 6300 Dumbarton Circle, Fremont, CA 94555 ("Asterias"), BioTime, Inc., a California corporation, having a place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("BioTime"), and ES Cell International Pte Ltd., a corporation wholly owned by BioTime organized under the laws of Singapore and having a place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("ESI") (each individually referred to as "Party" and collectively as the "Parties").

Anthem Inc. – Blue Cross License Agreement (February 19th, 2016)

WHEREAS, the Plan and/or its predecessor(s) in interest (collectively the "Plan") had the right to use the BLUE CROSS and BLUE CROSS Design service marks (collectively the "Licensed Marks") for health care plans in its service area, which was essentially local in nature;

CROSS LICENSE AGREEMENT Between ASTERIAS and BIOTIME and ESI (February 18th, 2016)

This CROSS-LICENSE AGREEMENT (the "Agreement") is entered into on February 16, 2016 (the "Effective Date") by and between Asterias Biotherapeutics, Inc., a Delaware corporation, having a place of business at 6300 Dumbarton Circle, Fremont, CA 94555 ("Asterias"), BioTime, Inc., a California corporation, having a place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("BioTime"), and ES Cell International Pte Ltd., a corporation wholly owned by BioTime organized under the laws of Singapore and having a place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("ESI") (each individually referred to as "Party" and collectively as the "Parties").

Asterias Biotherapeutics, Inc. – CROSS LICENSE AGREEMENT Between ASTERIAS and BIOTIME and ESI (February 18th, 2016)

This CROSS-LICENSE AGREEMENT (the "Agreement") is entered into on February 16, 2016 (the "Effective Date") by and between Asterias Biotherapeutics, Inc., a Delaware corporation, having a place of business at 6300 Dumbarton Circle, Fremont, CA 94555 ("Asterias"), BioTime, Inc., a California corporation, having a place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("BioTime"), and ES Cell International Pte Ltd., a corporation wholly owned by BioTime organized under the laws of Singapore and having a place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("ESI") (each individually referred to as "Party" and collectively as the "Parties").

GCP Applied Technologies Inc. – Cross License Agreement (January 28th, 2016)

GCP Applied Technologies Inc., a corporation organized and existing under the laws of Delaware, USA having an office at 62 Whittemore Ave., Cambridge, MA 02140-1623 (hereinafter referred to as "GCP");

Cross License Agreement (January 28th, 2016)

GCP Applied Technologies Inc., a corporation organized and existing under the laws of Delaware, USA having an office at 62 Whittemore Ave., Cambridge, MA 02140-1623 (hereinafter referred to as "GCP");

GCP Applied Technologies Inc. – Cross License Agreement (December 22nd, 2015)

GCP Applied Technologies Inc., a corporation organized and existing under the laws of Delaware, USA having an office at 62 Whittemore Ave., Cambridge, MA 02140-1623 (hereinafter referred to as "GCP");

Mirna Therapeutics, Inc. – Cross License Agreement (August 24th, 2015)

This Cross License Agreement (this Agreement) is made as of the Effective Date (as such term is defined below) by and between Asuragen, Inc., a Delaware corporation with its principal offices at 2150 Woodward St., Austin, Texas 78744 (Asuragen) and Mirna Therapeutics, Inc., a Delaware corporation with an office at 2150 Woodward Street, Austin, Texas 78744 (Mirna); (each of Asuragen and Mirna is referred to herein as Party and together as the Parties).

Mirna Therapeutics, Inc. – First Amendment to the Cross License Agreement (August 24th, 2015)

This First Amendment to the Cross License Agreement (the First Amendment) is by and between Mirna Therapeutics, Inc. (Mirna), a Delaware corporation with a principal business address at 2150 Woodward St., Suite 100, Austin, Texas 78744, and Asuragen, Inc., a Delaware corporation, with a principal business address at 2150 Woodward Street, Austin, Texas 78744 (Asuragen), and is effective as of September 28, 2012 (the First Amendment Effective Date). All capitalized terms not defined in this First Amendment shall have the meanings given to them in the Cross License Agreement (including Exhibits thereto) entered into by and between Mirna and Asuragen, effective as of November 3, 2009 (the Agreement).

Digicel Group Ltd – TRADEMARK CROSS LICENSE AGREEMENT Dated as of February 16, 2007 Between Digicel Holdings BV and Digicel Caribbean Limited (July 31st, 2015)

This TRADEMARK CROSS LICENSE AGREEMENT (this Agreement) dated February 16, 2007 (the Effective Date), between Digicel Holdings BV, (DH) a limited liability company incorporated under the laws of The Netherlands, and having its registered office at IMFC Management B.V., Amsteldijk 166, 1079 LH Amsterdam, The Netherlands, and having its principal office at the above address and Digicel Caribbean Limited (DCL), a corporation incorporated under the laws of St Lucia, and having its principal office at 1st Floor, Financial Centre, Bridge Street, Castries, St Lucia (each a Party and collectively, the Parties).

Intellectual Property Cross-License Agreement (July 15th, 2015)

THIS INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT (this Agreement) is entered into as of July 14, 2015 (the Effective Date) by and between Danaher Corporation, a Delaware corporation (Danaher) and Potomac Holding LLC, a Delaware limited liability company (the Newco and, collectively with Danaher, the Parties). Capitalized terms used herein without being defined in this Agreement shall have the respective meanings given such terms in the Separation and Distribution Agreement, dated as of October 12, 2014 (as amended, modified or supplemented from time to time in accordance with its terms, the Distribution Agreement), by and between Danaher and Newco.

Chemours Co – THIRD AMENDED AND RESTATED INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT by and Between and THE CHEMOURS COMPANY FC, LLC and THE CHEMOURS COMPANY TT, LLC Dated as of January 1, 2015 (July 1st, 2015)

This THIRD AMENDED AND RESTATED INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of January 1, 2015 (the Effective Date), is entered into by and between E. I. du Pont de Nemours and Company (DuPont), a Delaware corporation, The Chemours Company FC, LLC, a Delaware limited liability company with address at 1209 Orange Street, Wilmington, DE, 19801, U.S.A. (CHEMOURS FC), and The Chemours Company TT, LLC, a Pennsylvania limited liability company with address at 116 Pine Street, 3rd Floor, Suite 320, Harrisburg, PA, 17101, U.S.A. (CHEMOURS TT) (each of DuPont, CHEMOURS FC and CHEMOURS TT, a Party and collectively, the Parties).

Chemours Co – AMENDED AND RESTATED INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT by and Between and THE CHEMOURS COMPANY FC, LLC and THE CHEMOURS COMPANY TT, LLC Dated as of January 1, 2015 (April 21st, 2015)

This AMENDED AND RESTATED INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of January 1, 2015 (the Effective Date), is entered into by and between E. I. du Pont de Nemours and Company (DuPont), a Delaware corporation, The Chemours Company FC, LLC, a Delaware limited liability company with address at 1209 Orange Street, Wilmington, DE, 19801, U.S.A. (CHEMOURS FC), and The Chemours Company TT, LLC, a Pennsylvania limited liability company with address at 116 Pine Street, 3rd Floor, Suite 320, Harrisburg, PA, 17101, U.S.A. (CHEMOURS TT) (each of DuPont, CHEMOURS FC and CHEMOURS TT, a Party and collectively, the Parties).

Anthem Inc. – BLUE CROSS LICENSE AGREEMENT (Includes Revisions, if Any, Adopted by Member Plans Through Their November 21, 2014 Meeting) (February 24th, 2015)

WHEREAS, the Plan and/or its predecessor(s) in interest (collectively the "Plan") had the right to use the BLUE CROSS and BLUE CROSS Design service marks (collectively the "Licensed Marks") for health care plans in its service area, which was essentially local in nature;

*** - Indicates Material Omitted Pursuant to a Confidential Treatment Request and Filed Separately With the Securities and Exchange Commission. NIKON-ASML PATENT CROSS-LICENSE AGREEMENT (February 11th, 2015)

THIS NIKON-ASML PATENT CROSS-LICENSE AGREEMENT (this AGREEMENT) is made and entered into as of November 12, 2004 (the EFFECTIVE DATE) by and between ASML Holding N.V., a corporation organized under the laws of the Netherlands (ASML), and Nikon Corporation, a corporation organized under the laws of Japan (NIKON). ASML and Nikon are hereinafter also referred to collectively as the PARTIES and individually as a PARTY.

Intellectual Property Cross-License Agreement (January 9th, 2015)

THIS INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT (this Agreement) is entered into as of [], 201[] (the Effective Date) by and between Danaher Corporation, a Delaware corporation (Danaher) and Potomac Holding LLC, a Delaware limited liability company (the Newco and, collectively with Danaher, the Parties). Capitalized terms used herein without being defined in this Agreement shall have the respective meanings given such terms in the Separation and Distribution Agreement, dated as of October 12, 2014 (as amended, modified or supplemented from time to time in accordance with its terms, the Distribution Agreement), by and between Danaher and Newco.

Potomac Holding LLC – Intellectual Property Cross-License Agreement (January 9th, 2015)

THIS INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT (this Agreement) is entered into as of [], 201[] (the Effective Date) by and between Danaher Corporation, a Delaware corporation (Danaher) and Potomac Holding LLC, a Delaware limited liability company (the Newco and, collectively with Danaher, the Parties). Capitalized terms used herein without being defined in this Agreement shall have the respective meanings given such terms in the Separation and Distribution Agreement, dated as of October 12, 2014 (as amended, modified or supplemented from time to time in accordance with its terms, the Distribution Agreement), by and between Danaher and Newco.

Symmetry Surgical Inc. – Shared Ip Cross License Agreement Shared Ip Cross License Agreement (October 24th, 2014)

THIS SHARED IP CROSS LICENSE AGREEMENT (the "Agreement"), dated as of [ ], 2014 (the "Effective Date"), is made and entered into by and between Symmetry Medical Inc., a Delaware Corporation (the "Company"); and Racecar Spinco, Inc., a Delaware Corporation and a wholly owned Subsidiary of the Company ("SpinCo"). Company and SpinCo are referred to in this Agreement each as a "Party" and collectively as the "Parties."

Symmetry Surgical Inc. – Shared Ip Cross License Agreement Shared Ip Cross License Agreement (September 5th, 2014)

THIS SHARED IP CROSS LICENSE AGREEMENT (the "Agreement"), dated as of [*], 2014 (the "Effective Date"), is made and entered into by and between Symmetry Medical Inc., a Delaware Corporation (the "Company"); and Racecar Spinco, Inc., a Delaware Corporation and a wholly owned Subsidiary of the Company ("SpinCo"). Company and SpinCo are referred to in this Agreement each as a "Party" and collectively as the "Parties."

Intellectual Property Cross License Agreement (August 11th, 2014)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of August 5, 2014 (the Effective Date), is made and entered into by and between General Electric Company, a New York corporation (GE) and General Electric Capital Corporation, a Delaware corporation (GECC), on the one hand, and Synchrony Financial, a Delaware corporation (Company), on the other hand.

Intellectual Property Cross License Agreement (August 1st, 2014)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of [], 2014 (the Effective Date), is made and entered into by and between General Electric Company, a New York corporation (GE) and General Electric Capital Corporation, a Delaware corporation (GECC), on the one hand, and Synchrony Financial, a Delaware corporation (Company), on the other hand.

Intellectual Property Cross License Agreement (June 27th, 2014)

This INTELLECTUAL PROPERTY CROSS LICENSE AGREEMENT (this Agreement), dated as of [], 2014 (the Effective Date), is made and entered into by and between General Electric Company, a New York corporation (GE) and General Electric Capital Corporation, a Delaware corporation (GECC), on the one hand, and Synchrony Financial, a Delaware corporation (Company), on the other hand.

SunEdison Semiconductor Ltd – Patent and Technology Cross-License Agreement by and Between Sunedison, Inc. And Sunedison Semiconductor Limited Dated as of May 27, 2014 (June 2nd, 2014)

This Patent and Technology Cross-License Agreement (this Agreement), made and entered into as of May 27, 2014 and effective as of the Effective Date, is by and between SunEdison, Inc., a Delaware corporation (SunEdison), and SunEdison Semiconductor Limited, a Singapore corporation (Semi or SSL).

Settlement, Release and Cross-License Agreement (May 29th, 2014)

Pursuant to California Rules of Court, Rule 8.244(a)(1), Plaintiffs/Appellants Nir Zuk and Palo Alto Networks, Inc., hereby notify the Court that they have reached a settlement of the above captioned matter with Defendant/Respondent, Juniper Networks, Inc.